Kodiak Sciences Inc (KOD)
3.36
+0.15
(+4.67%)
USD |
NASDAQ |
May 22, 10:48
Kodiak Sciences Cash from Investing (TTM): 75.65M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 75.65M |
December 31, 2023 | 249.23M |
September 30, 2023 | 344.02M |
June 30, 2023 | 402.98M |
March 31, 2023 | -144.82M |
December 31, 2022 | -336.51M |
September 30, 2022 | -414.37M |
June 30, 2022 | -504.80M |
March 31, 2022 | -66.30M |
December 31, 2021 | -38.80M |
September 30, 2021 | 30.92M |
Date | Value |
---|---|
June 30, 2021 | 119.02M |
March 31, 2021 | 181.25M |
December 31, 2020 | 104.83M |
September 30, 2020 | -67.31M |
June 30, 2020 | -124.22M |
March 31, 2020 | -180.32M |
December 31, 2019 | -137.00M |
September 30, 2019 | -24.24M |
June 30, 2019 | -23.74M |
March 31, 2019 | -24.45M |
December 31, 2018 | -0.581M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-504.80M
Minimum
Jun 2022
402.98M
Maximum
Jun 2023
-27.73M
Average
-31.52M
Median
Cash from Investing (TTM) Benchmarks
Avalo Therapeutics Inc | 0.356M |
Regeneron Pharmaceuticals Inc | -4.636B |
Ligand Pharmaceuticals Inc | -26.01M |
iBio Inc | 1.044M |
Dare Bioscience Inc | -0.6367M |